If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:209860-87-7
Source:Europe
Qualifications:USDMF/-/-/-/-
| Name | Tafluprost |
|---|---|
| Chinese name | 他氟前列素 |
| Cas Number | 209860-87-7 |
| Source | Europe |
| Qualifications | USDMF/-/-/-/- |
It was first launched in Germany in 2008, and it was the first ophthalmic drug for prostaglandin analogs without preservatives. Prostaglandin analogs can increase the excretion of aqueous humor, thereby reducing intraocular pressure. The main drugs in the domestic glaucoma therapeutic drug market include five subcategories: cholinergic drugs, adrenergics, β-receptor antagonists, carbonic anhydrase inhibitors, and prostaglandins. The "Expert Consensus on the Diagnosis and Treatment of Primary Glaucoma in China" released in 2014 listed prostaglandin analogues as first-line drugs. The use of drugs in sample hospitals also showed that among glaucoma treatment drugs, prostaglandin analogues have been the best in recent years. Almost 50% of all glaucoma medications.
Hot Tags: tafluprost api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Gabapentin API, Tetrabenazine API, Cinacalcet Hydrochloride API, Paliperidone API, Vardenafil API, Perindopril Arginine API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
